SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis

SOX transcription factors are essential for embryonic development and play critical roles in cell fate determination, differentiation and proliferation. We previously reported that the SOX2 protein is expressed in normal gastric mucosae but downregulated in some human gastric carcinomas. To clarify the roles of SOX2 in gastric carcinogenesis, we carried out functional characterisation of SOX2 in gastric epithelial cell lines. Exogenous expression of SOX2 suppressed cell proliferation in gastric epithelial cell lines. Flow cytometry analysis revealed that SOX2-overexpressing cells exhibited cell-cycle arrest and apoptosis. We found that SOX2-mediated cell-cycle arrest was associated with decreased levels of cyclin D1 and phosphorylated Rb, and an increased p27Kip1 level. These cells exhibited further characteristics of apoptosis, such as DNA laddering and caspase-3 activation. SOX2 hypermethylation signals were observed in some cultured and primary gastric cancers with no or weak SOX2 expression. Among the 52 patients with advanced gastric cancers, those with cancers showing SOX2 methylation had a significantly shorter survival time than those without this methylation (P=0.0062). Hence, SOX2 plays important roles in growth inhibition through cell-cycle arrest and apoptosis in gastric epithelial cells, and the loss of SOX2 expression may be related to gastric carcinogenesis and poor prognosis.

[1]  L. Johnson.  Regulation of gastrointestinal mucosal growth , 1979, World Journal of Surgery.

[2]  Y. Yuasa.  Control of gut differentiation and intestinal-type gastric carcinogenesis , 2003, Nature Reviews Cancer.

[3]  H. Kondoh,et al.  Pairing SOX off: with partners in the regulation of embryonic development. , 2000, Trends in genetics : TIG.

[4]  H. Eguchi,et al.  p27kip1 regulates the apoptotic response of gastric epithelial cells to Helicobacter pylori , 2004, Gut.

[5]  W. Leung,et al.  Upregulation of heme oxygenase-1 and p21 confers resistance to apoptosis in human gastric cancer cells , 2004, Oncogene.

[6]  A. Gartel,et al.  The Role of the Cyclin-dependent Kinase Inhibitor p 21 in Apoptosis 1 , 2002 .

[7]  D. Ambrosetti,et al.  Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation , 2005, The Journal of cell biology.

[8]  T. Ørntoft,et al.  SOX4 expression in bladder carcinoma: clinical aspects and in vitro functional characterization. , 2006, Cancer research.

[9]  R. Lovell-Badge,et al.  Sox genes find their feet. , 1997, Current opinion in genetics & development.

[10]  F. McCormick,et al.  Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. , 1999, Nature.

[11]  N. Corbi,et al.  Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. , 1995, Genes & development.

[12]  P. Blache,et al.  Expression of the carcinoembryonic antigen gene is inhibited by SOX9 in human colon carcinoma cells. , 2005, Cancer research.

[13]  M. S. Lee,et al.  Expression of p27Kip1 and cyclin D1 proteins is inversely correlated and is associated with poor clinical outcome in human gastric cancer , 1999, Journal of surgical oncology.

[14]  C. Sherr.  The Pezcoller lecture: cancer cell cycles revisited. , 2000, Cancer research.

[15]  T. Tsukamoto,et al.  Down-regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: inverse correlation during progression from gastric/intestinal-mixed to complete intestinal metaplasia , 2004, Journal of Cancer Research and Clinical Oncology.

[16]  J. Herman,et al.  A gene hypermethylation profile of human cancer. , 2001, Cancer research.

[17]  M. Blaser,et al.  Helicobacter pylori and gastrointestinal tract adenocarcinomas , 2002, Nature Reviews Cancer.

[18]  K. Yanagihara,et al.  Transcription factor SOX2 up-regulates stomach-specific pepsinogen A gene expression , 2007, Journal of Cancer Research and Clinical Oncology.

[19]  Y. Eishi,et al.  Expression of the SRY-related HMG box protein SOX2 in human gastric carcinoma. , 2004, International journal of oncology.

[20]  K. Mimori,et al.  p27 expression and gastric carcinoma , 1997, Nature Medicine.

[21]  S. Elledge,et al.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.

[22]  P. Koopman,et al.  Matching SOX: partner proteins and co-factors of the SOX family of transcriptional regulators. , 2002, Current opinion in genetics & development.

[23]  M. Sakaguchi,et al.  Establishment and characterization of a rat pepsin-producing gastric cell line (oums-37) , 1999, In Vitro Cellular & Developmental Biology - Animal.

[24]  M. Rex,et al.  Region‐specific expression of chicken Sox2 in the developing gut and lung epithelium: Regulation by epithelial‐mesenchymal interactions , 1998, Developmental dynamics : an official publication of the American Association of Anatomists.

[25]  Alan D. Lopez,et al.  Global and regional estimates of cancer mortality and incidence by site: II. results for the global burden of disease 2000 , 2002, BMC Cancer.

[26]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[27]  S. Burdach,et al.  CpG island methylation and expression of tumour-associated genes in lung carcinoma. , 2005, European journal of cancer.

[28]  M. Wegner,et al.  From head to toes: the multiple facets of Sox proteins. , 1999, Nucleic acids research.

[29]  V. Lefebvre,et al.  The Transcription Factor SOX9 Regulates Cell Cycle and Differentiation Genes in Chondrocytic CFK2 Cells* , 2001, The Journal of Biological Chemistry.

[30]  Tao Zhang,et al.  SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells. , 2007, Cancer research.

[31]  J. Herman,et al.  GATA-4 and GATA-5 Transcription Factor Genes and Potential Downstream Antitumor Target Genes Are Epigenetically Silenced in Colorectal and Gastric Cancer , 2003, Molecular and Cellular Biology.

[32]  B. Raaka,et al.  RAR agonists stimulate SOX9 gene expression in breast cancer cell lines: evidence for a role in retinoid-mediated growth inhibition , 2002, Oncogene.

[33]  C. Kitanaka,et al.  Apoptosis in cancer. , 1996, Human cell.

[34]  S. Baylin,et al.  Frequent epigenetic silencing of the bone morphogenetic protein 2 gene through methylation in gastric carcinomas , 2006, Oncogene.

[35]  P. Nelson,et al.  Suppression of growth and tumorigenicity in the prostate tumor cell line M12 by overexpression of the transcription factor SOX9 , 2004, Oncogene.

[36]  K. Kinzler,et al.  A simplified system for generating recombinant adenoviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.